Researchers at Children’s Hospital, University Medical Center Ljubljana, Slovenia; Molecular Neurogenetics, Milan, Italy; and Paracelsus Medical University, Salzburg, Austria, evaluated the functional outcome of 22 children with mitochondrial diseases.
